Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Megapolitan Developments Tbk. (EMDE) vs UBC Medical Indonesia Tbk. (LABS)

Megapolitan Developments Tbk.Trading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Megapolitan Developments Tbk. dan UBC Medical Indonesia Tbk.: Megapolitan Developments Tbk. diperdagangkan di Rp78 (kapitalisasi pasar 264,65 M, volume 24 jam 4,45 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 691,25 M, volume 24 jam 635,5 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 2,6× kapitalisasi pasar Megapolitan Developments Tbk., dan Megapolitan Developments Tbk. lebih aktif diperdagangkan (4,45 jt vs 635,5 rb). Mana yang lebih baik tergantung tujuan investasimu.

EMDELABS
Kapitalisasi Pasar
264,65 M691,25 M
Volume
4,45 jt635,5 rb
Lot
44,48 rb6,36 rb
Perputaran
344,65 jt110,15 jt
Harga Rata-rata
77,48173,33
Nilai Transaksi
344,65 jt110,15 jt
Harga Ekuilibrium Indikatif
78174
Volume Ekuilibrium Indikatif
85350

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

EMDE
Lihat detail
LABS
Lihat detail

Tentang Megapolitan Developments Tbk.

PT Megapolitan Developments (formerly Megapolitan Developments Corporation) (the Company) was established based on Notary Deed No. 24 dated September 10, 1976 by Soeleman Ardjasasmita, S.H., Notary in Jakarta.

Selengkapnya di halaman EMDE

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS